Zhongyuan Qu

637 total citations · 1 hit paper
34 papers, 481 citations indexed

About

Zhongyuan Qu is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Zhongyuan Qu has authored 34 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Zhongyuan Qu's work include Pharmacological Effects of Natural Compounds (8 papers), Natural product bioactivities and synthesis (4 papers) and Tryptophan and brain disorders (4 papers). Zhongyuan Qu is often cited by papers focused on Pharmacological Effects of Natural Compounds (8 papers), Natural product bioactivities and synthesis (4 papers) and Tryptophan and brain disorders (4 papers). Zhongyuan Qu collaborates with scholars based in China, United Kingdom and South Korea. Zhongyuan Qu's co-authors include Zou Xiang, JI Yu-bin, Chenfeng Ji, Zhiwei Sun, Shoudong Guo, Yanjie Li, Wenlan Li, Xin Shi, Xiang Zou and Shuang Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Journal of Ethnopharmacology.

In The Last Decade

Zhongyuan Qu

32 papers receiving 468 citations

Hit Papers

Targeting the PDGF/PDGFR signaling pathway for cancer the... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongyuan Qu China 10 251 71 63 63 53 34 481
Yaoxian Wang China 11 240 1.0× 61 0.9× 78 1.2× 55 0.9× 105 2.0× 18 514
Yewseok Suh United States 10 377 1.5× 42 0.6× 59 0.9× 69 1.1× 74 1.4× 14 661
Zhaohai Pan China 12 251 1.0× 35 0.5× 73 1.2× 52 0.8× 56 1.1× 18 478
Zhihua Li China 11 286 1.1× 38 0.5× 67 1.1× 77 1.2× 75 1.4× 32 681
Ming-Jen Fan Taiwan 12 249 1.0× 73 1.0× 67 1.1× 41 0.7× 120 2.3× 14 494
Ching-Lung Liao Taiwan 13 284 1.1× 43 0.6× 93 1.5× 76 1.2× 83 1.6× 14 506
Ying Hou China 17 441 1.8× 43 0.6× 130 2.1× 77 1.2× 53 1.0× 30 735
Wafaa S. Ramadan United Arab Emirates 14 346 1.4× 27 0.4× 53 0.8× 103 1.6× 60 1.1× 39 627
Srinivas Reddy Boreddy United States 7 353 1.4× 36 0.5× 97 1.5× 80 1.3× 39 0.7× 11 521
Min Kyoung Kim South Korea 14 193 0.8× 43 0.6× 29 0.5× 75 1.2× 71 1.3× 31 505

Countries citing papers authored by Zhongyuan Qu

Since Specialization
Citations

This map shows the geographic impact of Zhongyuan Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongyuan Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongyuan Qu more than expected).

Fields of papers citing papers by Zhongyuan Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongyuan Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongyuan Qu. The network helps show where Zhongyuan Qu may publish in the future.

Co-authorship network of co-authors of Zhongyuan Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongyuan Qu. A scholar is included among the top collaborators of Zhongyuan Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongyuan Qu. Zhongyuan Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Zou, et al.. (2025). Mechanism elucidation and biochemometric-based screening of substances in Schisandra chinensis leaves for alcoholic liver injury. Phytomedicine. 142. 156757–156757. 9 indexed citations
2.
Li, Jianli, et al.. (2025). Chelidonine-induced inhibition of FBP1 disrupts M2 macrophage polarization and attenuates breast cancer. Phytomedicine. 148. 157451–157451. 1 indexed citations
3.
Qu, Zhongyuan, et al.. (2025). Regulation of inflammation by Chaihu-Shugan-San: Targeting the IL-17/ NF-κB pathway to combat breast cancer-related depression. Phytomedicine. 143. 156836–156836. 10 indexed citations
4.
Li, Zehao, Lin Liu, Dongxue Wang, et al.. (2025). Preliminary exploration of the antidepressant mechanism of Bupleurum scorzonerifolium-Scutellaria baicalensis and its core SSa-Baicalin combination. Journal of Ethnopharmacology. 353(Pt B). 120426–120426. 3 indexed citations
5.
Wu, Jianping, Long Xie, Zhongyuan Qu, et al.. (2025). Exploring the active components of hypoglycemic effect in different polar fractions of Inonotus obliquus based on spectrum-effect relationship. Journal of Functional Foods. 127. 106767–106767. 2 indexed citations
6.
Li, Zehao, Shuang Wu, Tianlei Zhang, et al.. (2025). A comprehensive review of the botany, traditional uses, phytochemistry, pharmacology, processing and quality evaluation of Bupleurum scorzonerifolium Willd. Journal of Ethnopharmacology. 354. 120475–120475. 2 indexed citations
7.
Ji, Xiaoling, et al.. (2025). Antidepressant efficacy and Q-markers determination of Dachaihu decoction: Combining pharmacology, correlation analysis, and network pharmacology approaches. Journal of Pharmaceutical and Biomedical Analysis. 267. 117169–117169. 1 indexed citations
9.
Zhao, Ming, et al.. (2025). Reverse traceability analysis of estrogenic active ingredients in Cuscutae semen based on intestinal and hepatic metabolism. Journal of Pharmaceutical and Biomedical Analysis. 260. 116819–116819. 1 indexed citations
10.
Qu, Zhongyuan, et al.. (2024). Discovery and verification of antidepressant active ingredients of raw and vinegar-processed Bupleurum marginatum var. Stenophyllum based on plant metabolomics and serum pharmacology. Journal of Pharmaceutical and Biomedical Analysis. 246. 116239–116239. 4 indexed citations
12.
Qu, Zhongyuan, Shuang Wu, Yan Zheng, et al.. (2023). Fecal metabolomics combined with metagenomics sequencing to analyze the antidepressant mechanism of Yueju Wan. Journal of Pharmaceutical and Biomedical Analysis. 238. 115807–115807. 5 indexed citations
14.
Wu, Shuang, et al.. (2022). Bupleurum scorzonerifolium: Systematic research through pharmacodynamics and serum pharmacochemistry on screening antidepressant Q-markers for quality control. Journal of Pharmaceutical and Biomedical Analysis. 225. 115202–115202. 14 indexed citations
15.
Xiang, Zou, Zhongyuan Qu, Zhiwei Sun, et al.. (2022). Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review. International Journal of Biological Macromolecules. 202. 539–557. 146 indexed citations breakdown →
16.
Yang, Yibo, et al.. (2020). First Report of Purple Spot on Dandelion in China Caused by Alternaria tenuissima. Plant Disease. 105(1). 211–211. 2 indexed citations
17.
Yu-bin, JI, et al.. (2016). Mechanism of juglone-induced apoptosis of MCF-7 cells by the mitochondrial pathway. Genetics and Molecular Research. 15(3). 19 indexed citations
18.
Xiang, Zou, et al.. (2016). Endoplasmic reticulum stress mediates sulforaphane-induced apoptosis of HepG2 human hepatocellular carcinoma cells. Molecular Medicine Reports. 15(1). 331–338. 24 indexed citations
19.
Qu, Zhongyuan, Xiang Zou, Xiujuan Zhang, et al.. (2015). Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells. Molecular Medicine Reports. 13(2). 1336–1344. 16 indexed citations
20.
Yu-bin, JI, Zhongyuan Qu, Xiang Zou, & Chenfeng Ji. (2010). Effects of Juglone on ROS Production and Mitochondrial Transmembrane Potential in SGC-7901 Cells. International Conference on Bioinformatics and Biomedical Engineering. 1–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026